Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission von Narula, Neeraj, Wong, Emily C. L., Dulai, Parambir S., Marshall, John K., Jairath, Vipul, Reinisch, Walter

Volltext

Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study von Wong, Emily C. L., Merat, Shahin, Monaco, Cristina, Dulai, Parambir S., Jairath, Vipul, Marshall, John K., Reinisch, Walter, Narula, Neeraj

Volltext

Resolution of dominant patient‐reported outcome at end of induction predicts clinical and endoscopic remission in Crohn’s disease von Wong, Emily C.L., Dulai, Parambir S., Marshall, John K., Jairath, Vipul, Reinisch, Walter, Narula, Neeraj

Volltext

The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies von Narula, Neeraj, Aruljothy, Achuthan, Wong, Emily C. L., Homenauth, Ravi, Alshahrani, Abdul‐Aziz, Marshall, John K., Reinisch, Walter

Volltext

Transcriptional Regulation of the Kaposi's Sarcoma-Associated Herpesvirus K15 Gene von WONG, Emily L, DAMANIA, Blossom

Volltext

Correspondence on “PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicti... von Wong, Emily C L, Dulai, Parambir S, Narula, Neeraj

Volltext

Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis von Narula, Neeraj, Chang, Nicole H., Mohammad, Danah, Wong, Emily C.L., Ananthakrishnan, Ashwin N., Chan, Simon S.M., Carbonnel, Franck, Meyer, Antoine

Volltext

Predicting endoscopic remission in Crohn’s disease by the modified multiplier SES-CD (MM-SES-CD) von Narula, Neeraj, Wong, Emily C L, Colombel, Jean-Frederic, Sandborn, William J, Marshall, John Kenneth, Daperno, Marco, Reinisch, Walter, Dulai, Parambir S

Volltext

Identification and Characterization of the Orf49 Protein of Kaposi's Sarcoma-Associated Herpesvirus von GONZALEZ, Carlos M, WONG, Emily L, BOWSER, Brian S, HONG, Gregory K, KENNEY, Shannon, DAMANIA, Blossom

Volltext

Does a High-inflammatory Diet Increase the Risk of Inflammatory Bowel Disease? Results From the Prospective Urban Rural Epidemiology (PURE) Study: A Prospective Cohort Study von Narula, Neeraj, Wong, Emily C.L., Dehghan, Mahshid, Marshall, John K., Moayyedi, Paul, Yusuf, Salim

Volltext

Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative Colitis von Narula, Neeraj, Wong, Emily C.L., Colombel, Jean-Frederic, Riddell, Robert, Marshall, John K., Reinisch, Walter, Dulai, Parambir S.

Volltext

Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease von Narula, Neeraj, Wong, Emily C.L., Dulai, Parambir S., Sengupta, Neil K., Marshall, John K., Colombel, Jean-Frederic, Reinisch, Walter

Volltext

Beyond the White Pill: Advocating for Racial Diversity in IBD Trials von Wong, Emily C L, Moayyedi, Paul, Narula, Neeraj

Volltext

Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression von Narula, Neeraj, Wong, Emily C.L., Dulai, Parambir S., Patel, Jaiminkumar, Marshall, John K., Yzet, Clara, Jairath, Vipul, Ungaro, Ryan, Colombel, Jean-Frederic, Reinisch, Walter

Volltext

Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders von Wong, Emily C L, Dulai, Parambir S, Marshall, John K, Jairath, Vipul, Reinisch, Walter, Narula, Neeraj

Volltext

Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn’s Disease: A Post Hoc Analysis of the IM-UNITI Trial von Wong, Emily C L, Marshall, John K, Reinisch, Walter, Narula, Neeraj

Volltext

Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis von Narula, Neeraj, Wong, Emily C.L., Marshall, John K., Colombel, Jean-Frederic, Dulai, Parambir S., Reinisch, Walter

Volltext

Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn’s Disease von Wong, Emily C L, Dulai, Parambir S, Marshall, John K, Jairath, Vipul, Reinisch, Walter, Narula, Neeraj

Volltext

Clinical Decision Support Tool for Infliximab in Crohn’s Disease von Dulai, Parambir S., Wong, Emily C.L., Reinisch, Walter, Narula, Neeraj

Volltext

Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab von Dulai, Parambir S, Wong, Emily C L, Reinisch, Walter, Colombel, Jean-Frederic, Marshall, John K, Narula, Neeraj

Volltext